CC

CFS Capital

North America, Washington, United States, Spokane

Description

CFS Capital is an investment firm.

Investor Profile

CFS Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series D rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biotechnology.

Stage Focus

  • Series D (100%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CFS Capital frequently co-invest with?

Co-Investments: 1
FengHe Fund Management
Asia, Guangdong, China, Huangpu
Co-Investments: 1
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
BB
Asia, Kagoshima, Japan, China
Co-Investments: 1
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 1
ShenZhen GTJA Investment Group
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Xiamen Changrong Investment Management
Asia, Fujian, China, Xiamen
Co-Investments: 1

What are some of recent deals done by CFS Capital?

VivaVision Biotech

Shanghai, Shanghai, China

VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.

Biotechnology
Series DApr 21, 2021
Amount Raised: $46,217,840